# Lonza Biologics, Inc. - Inspection Records Source: https://www.globalkeysolutions.net/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff > Inspection records and compliance data for Lonza Biologics, Inc. in Portsmouth, New Hampshire. Access full analysis and detailed observations. --- ## Details - Name: Lonza Biologics, Inc. - FEI Number: 3001451441 - City: Portsmouth - State: New Hampshire - Country Name: United States - Address Line 1: 101 International Dr - Zip Code: 03801 ## Related Documents - [483 - Lonza Biologics, Inc. - 2026-04-16](https://www.globalkeysolutions.net/records/483/lonza-biologics-inc/7b621acc-25b2-419b-b47c-63946c125023) — source: FDA, date: April 16, 2026 - [FDA Inspection 1304046 - Lonza Biologics, Inc. - 2026-02-06](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/f423c98c-ca42-48ca-aa3a-6cfd4e863518) — source: FDA, date: February 6, 2026 - [FDA Inspection 1304046 - Lonza Biologics, Inc. - 2026-02-06](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/6829aae3-393f-4927-a6eb-2cdeb1a281e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 6, 2026 - [483 - Lonza Biologics, Inc. - 2025-06-06](https://www.globalkeysolutions.net/records/483/lonza-biologics-inc/b183451f-e08e-4fc2-b16f-6016c1be5c25) — source: FDA, date: June 6, 2025 - [483 - Lonza Biologics, Inc. - 2025-06-06](https://www.globalkeysolutions.net/records/483/lonza-biologics-inc/7e2c12cc-7bee-4578-9e3c-7e55036f3e8e) — source: FDA, date: June 6, 2025 - [FDA Inspection 1269735 - Lonza Biologics, Inc. - 2025-06-06](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/764dd13f-c7b5-4dc4-a6d1-c66b08767132) — source: FDA, date: June 6, 2025 - [483 - Lonza Biologics, Inc. - 2024-03-07](https://www.globalkeysolutions.net/records/483/lonza-biologics-inc/a5417b6a-1ebe-4cd5-8ba7-eae412f0931f) — source: FDA, date: March 7, 2024 - [FDA Inspection 1232144 - Lonza Biologics, Inc. - 2024-03-07](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/27bf4b1b-9774-4fae-ab31-cccbdc39d416) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2024 - [FDA Inspection 1232144 - Lonza Biologics, Inc. - 2024-03-07](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/d26d327b-7e5e-44dc-a11f-5a0ed641f62d) — classification: No Action Indicated (NAI), source: FDA, date: March 7, 2024 - [483 - Lonza Biologics, Inc. - 2023-07-21](https://www.globalkeysolutions.net/records/483/lonza-biologics-inc/868ee773-89d9-4285-aa55-f226970279fa) — source: FDA, date: July 21, 2023 - [FDA Inspection 1210690 - Lonza Biologics, Inc. - 2023-07-21](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/fa6c0e5e-762e-44f9-b5cd-483c8003242f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2023 - [483 - Lonza Biologics, Inc. - 2021-10-22](https://www.globalkeysolutions.net/records/483/lonza-biologics-inc/6e82b09e-669e-408f-9fb6-6063c2bbc0b0) — source: FDA, date: October 22, 2021 - [483 - Lonza Biologics, Inc. - 2020-11-03](https://www.globalkeysolutions.net/records/483/lonza-biologics-inc/1c4dc8ba-78a2-4438-b100-d4cfaa927f37) — source: FDA, date: November 3, 2020 - [FDA Inspection 1028939 - Lonza Biologics, Inc. - 2017-09-21](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/db419acd-b0d3-4e28-a649-9f42bc3edea4) — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2017 - [FDA Inspection 988692 - Lonza Biologics, Inc. - 2016-08-26](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/59c02fcb-6426-4f57-9094-3a6566e4d6aa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2016 - [FDA Inspection 914920 - Lonza Biologics, Inc. - 2015-02-10](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/e23f79c4-c1e8-4863-aa4e-cf62acbc5438) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2015 - [FDA Inspection 850896 - Lonza Biologics, Inc. - 2013-09-30](https://www.globalkeysolutions.net/records/fda_inspections/lonza-biologics-inc/456932aa-37e5-4761-8a1a-3e2e66a71fe9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2013 ## Related Companies - [Shilpa Pharma Lifesciences Limited](https://www.globalkeysolutions.net/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff) - [Apitoria Pharma Private Limited](https://www.globalkeysolutions.net/companies/apitoria-pharma-private-limited/7a543877-97f7-4c4a-8dc8-74ee9d1c0caf) - [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.globalkeysolutions.net/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc) - [Shionogi Pharma Co. Ltd.](https://www.globalkeysolutions.net/companies/shionogi-pharma-co-ltd/d403b7f0-ba88-4145-a303-36fd7f698ff2) - [MacroGenics, Inc](https://www.globalkeysolutions.net/companies/macrogenics-inc/aaffc8e7-a7dc-4595-a5fb-2e95ee9315d1) - [Spark Therapeutics, Inc.](https://www.globalkeysolutions.net/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd) - [Bachem Americas, Inc.](https://www.globalkeysolutions.net/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad) - [Apitoria Pharma Private Limited](https://www.globalkeysolutions.net/companies/apitoria-pharma-private-limited/c56154eb-1a77-4f64-9db0-4ae380d6b65e) - [Solara Active Pharma Sciences Limited](https://www.globalkeysolutions.net/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264) - [Novacyl Roussillon](https://www.globalkeysolutions.net/companies/novacyl-roussillon/5a1bc6b5-5b17-4058-9698-82735b553d87) ## Related Officers - [Jacek Cieslak](https://www.globalkeysolutions.net/people/jacek-cieslak/81b12add-49f1-4dfd-bcb1-60bc5b212b68) - [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942) - [Obina Echeozo](https://www.globalkeysolutions.net/people/obina-echeozo/7d5adbd7-367a-4426-9f14-69efd812fc6b) - [FDA_PERSONNEL](https://www.globalkeysolutions.net/people/pete-amin/7f032e7a-1dfc-4240-ba8d-2bba5f7e5b6b) - [Robert J. Martin](https://www.globalkeysolutions.net/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)